Hyperlipoproteinemia Type IIa
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Occurrence of multiple aberrantly spliced mRNAs of the LDL-receptor gene upon a donor splice site mutation that causes familial hypercholesterolemia (FHBenevento).
|
7545204 |
1995 |
Hyperlipoproteinemia Type IIa
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
The objective of this study was to report the frequency and spectrum of variants in LDLR in a cohort of Sri Lankan patients with FH.
|
29720182 |
2018 |
Hyperlipoproteinemia Type IIa
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
DNA of eight unrelated individuals with clinically diagnosed FH were analyzed using a High-Resolution Melting method (HRM) for the LDLR gene (coding region, promoter and intron/exon boundaries), the APOB gene (part exon 26) and the PCSK9 gene (exon7).
|
23130880 |
2013 |
Hyperlipoproteinemia Type IIa
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
We used a multiplex-PCR based single-strand conformation polymorphism analysis to screen the promotor region and all 18 exons of the LDL receptor gene for mutations in patients clinically diagnosed as having FH to identify their particular gene defect.
|
9512963 |
1998 |
Hyperlipoproteinemia Type IIa
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
In conclusion, we identified 5 missense mutations and 1 large deletion in LDLR gene, including 1 novel mutation in Han Chinese with FH in Taiwan.
|
16092059 |
2005 |
Hyperlipoproteinemia Type IIa
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Familial hypercholesterolemia (FH) and familial defective apolipoprotein B-100 (FDB) are relatively common lipid disorders caused by mutations of the low-density lipoprotein receptor (LDLR) and apolipoprotein B (apoB) genes, respectively.
|
16314194 |
2006 |
Hyperlipoproteinemia Type IIa
|
0.800 |
Biomarker
|
disease |
BEFREE |
Familial hypercholesterolemia (FH) is a genetic hyperlipidemia characterized by elevated concentrations of plasma LDL cholesterol.
|
30700805 |
2019 |
Hyperlipoproteinemia Type IIa
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Here, we present the generation of corrected hepatocyte-like cells (HLCs) from hiPSCs of a familial hypercholesterolemia (FH) patient with a homozygous mutation in the low-density lipoprotein receptor (LDLR) gene.
|
23247991 |
2013 |
Hyperlipoproteinemia Type IIa
|
0.800 |
Biomarker
|
disease |
BEFREE |
Eight novel mutations and functional impairments of the LDL receptor in familial hypercholesterolemia in the north of Japan.
|
11916007 |
2002 |
Hyperlipoproteinemia Type IIa
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Twelve familial hypercholesterolemia (FH) patients of different ancestries living in South Africa were subjected to mutation analysis of the low-density lipoprotein receptor (LDLR) gene.
|
9664576 |
1998 |
Hyperlipoproteinemia Type IIa
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the low-density lipoprotein receptor (LDLR) gene resulting in familial hypercholesterolemia have strong association with premature atherosclerosis.
|
12476935 |
2002 |
Hyperlipoproteinemia Type IIa
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Familial hypercholesterolemia (FH) is an autosomal dominant disease caused by a multitude of low density lipoprotein receptor (LDL-R) mutations.
|
8882879 |
1996 |
Hyperlipoproteinemia Type IIa
|
0.800 |
AlteredExpression
|
disease |
BEFREE |
These newly identified mutations cosegregated in their family members with defective LDL receptor activity and hypercholesterolemia, and are thought to be causal for the FH phenotype.
|
10447263 |
1999 |
Hyperlipoproteinemia Type IIa
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
During a survey of Italian patients with familial hypercholesterolemia (FH), we identified an FH heterozygous patient with a gross rearrangement of the low density lipoprotein (LDL) receptor gene.
|
1999337 |
1991 |
Hyperlipoproteinemia Type IIa
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Familial hypercholesterolemia (FH) results from low-density lipoprotein (LDL) receptor gene mutations.
|
15725694 |
2005 |
Hyperlipoproteinemia Type IIa
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
The recent isolation of the LDL receptor gene now makes it possible to use restriction fragment length polymorphisms to study the inheritance of the defective allele in families with familial hypercholesterolemia.
|
2904255 |
1989 |
Hyperlipoproteinemia Type IIa
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
DNA deletions in the low density lipoprotein (LDL) receptor gene in Danish families with familial hypercholesterolemia.
|
1863993 |
1991 |
Hyperlipoproteinemia Type IIa
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
DNA from 40 unrelated familial hypercholesterolemia (FH) heterozygotes were subjected to analyses of single-strand conformation polymorphisms (SSCPs) of exon 10 of the low density lipoprotein receptor (LDLR) gene.
|
8103503 |
1993 |
Hyperlipoproteinemia Type IIa
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Over a thousand low-frequency variants in <i>LDLR, APOB</i> and <i>PCSK9</i> have been implicated in FH but few have been examined at the population level.
|
31106297 |
2018 |
Hyperlipoproteinemia Type IIa
|
0.800 |
AlteredExpression
|
disease |
BEFREE |
This pathway may constitute a backup mechanism to LDL receptor-mediated pathways for the catabolism of these lipoproteins, which could be particularly relevant in subjects with high levels of apoB-containing lipoproteins, such as those occurring in patients with FH.
|
12519372 |
2003 |
Hyperlipoproteinemia Type IIa
|
0.800 |
Biomarker
|
disease |
BEFREE |
Our findings demonstrate that the Ldlr KO hamster is an animal model of choice for human FH and has great potential in translational research of hyperlipidemia and coronary heart disease.
|
29289533 |
2018 |
Hyperlipoproteinemia Type IIa
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Familial hypercholesterolemia (FH) is a common autosomal disorder associated with hypercholesterolemia which usually results from a mutation in the coding region of the low density lipoprotein (LDL) receptor (R) activity.
|
20826022 |
2011 |
Hyperlipoproteinemia Type IIa
|
0.800 |
Biomarker
|
disease |
BEFREE |
The distinction between FH and FDB may have therapeutic implications, because certain lipid lowering drugs act by stimulation of the LDL receptor, which has a normal function in FDB.
|
1632851 |
1992 |
Hyperlipoproteinemia Type IIa
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Familial hypercholesterolemia in South African Afrikaners. PvuII and StuI DNA polymorphisms in the LDL-receptor gene consistent with a predominating founder gene effect.
|
2887506 |
1987 |
Hyperlipoproteinemia Type IIa
|
0.800 |
Biomarker
|
disease |
BEFREE |
Knowledge of the impact of a mutation on the LDLR protein structure and function is very important for the diagnosis and management of FH.
|
27175606 |
2016 |